Immunovia, a diagnostics company focused on increasing pancreatic cancer survival through early detection, will move its lab and U.S. headquarters to Research Triangle Park in North Carolina in May 2024. This move follows successful model development and discovery phase completion. The company aims to confirm the analytical validity of its new test and conduct a large clinical validation study under the leadership of Dr. Lisa Ford. The move supports Immunovia's strategy to streamline operations and reduce costs, with Research Triangle Park providing access to top talent at a lower cost.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.